Factors associated with mortality of patients diagnosed with covid-19 in an emergency department
DOI:
https://doi.org/10.51723/hrj.v5i25.1079Keywords:
Mortality, Emergency Medical Services., COVID-19Abstract
Objective: To analyze the factors associated with mortality among patients diagnosed with COVID-19 in a public emergency department in the Distrito Federal. Methods: A cross-sectional study was conducted based on the analysis of 382 electronic medical records of patients diagnosed with COVID, considering the periods of highest incidence from March 2020 to May 2021. Patients over 14 years, diagnosed with COVID-19 and admitted to the emergency department, were included. Patients who did not present data related to the outcome of the emergency department visit, had incomplete medical records, or had an inconclusive diagnosis of COVID-19 were excluded. Data were summarized in Google Forms and later in Microsoft Excel 2013 software. Descriptive and inferential analysis was performed using SPSS Statistics 23 softwares. Results: The majority of participants were male, aged 61 to 80 years, and were classified with acute respiratory syndrome. Among the variables associated with mortality, the most notable were classification with severe acute respiratory syndrome, age group, orotracheal intubation, waiting time in the emergency department for admission to an intensive care unit bed, and use of antibiotics. The average length of stay for patients who died in the emergency department was 6.08 days, and for those intubated, it was seven days. Conclusions: The use of secondary data may suffer from information bias, and the omission of records in medical records complicates data collection and analysis.
References
World Health Organization. Coronavirus disease (COVID-2019): Situation Report 2020. Geneva: WHO; 2020 [cited 2023 Mar 20]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen
Tali SHS, LeBlanc JJ, Sadiq Z, Oyewunmi OD, Camargo C, Nikpour B, Armanfard N, Sagan SM, Jahanshani-Anbuhi S, et al. Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection. Clin Microbiol, 2021; 34(3): e00228-20. Avaliable from: https://journals.asm.org/doi/epub/10.1128/cmr.00228-20. doi: https://doi.org/10.1128/cmr.00228-20
World Health Organization. Rolling updates on coronavirus disease (COVID-19). 2020 July 31 [cited 2021 Jun 23]. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200211-sitrep-22-ncov.pdf?sfvrsn=fb6d49b1_2.
Figueiredo AM, Figueiredo DCMM, Gomes LB, Massuda A, Gil-García E, Vianna RPT, et al. Social determinants of health and COVID-19 infection in Brazil: an analysis of the pandemic. Rev Bras Enferm. 2020;73(Suppl 2):e20200673. Disponivel em: https://www.scielo.br/j/reben/a/H9BxWMp6bK9QNLkpPBqJhBw/?format=pdf&lang=pt doi: http://dx.doi.org/10.1590/0034-7167-2020-0673
Escosteguy CC, Eleuterio TA, Pereira AGL, Marques MRVE, Brandão AD, Batista JPM, et al. COVID-19: a cross-sectional study of suspected cases admitted to a federal hospital in Rio de Janeiro, Brazil, and factors associated with hospital death. Epidemiol Serv Saude. 2021; 30(1):e2020750. Disponível em: https://www.scielo.br/j/ress/a/6yyZsFZxCnVTk9sqwvYFhfN/?format=pdf&lang=pt. doi: 10.1590/S1679-49742021000100023.
Brasil. Secretaria de Estado de Saúde de Santa Catarina. Manual de Orientações da COVID-19 (vírus SARS-CoV-2) [Internet]. Santa Catarina (SC): Governo de Santa Catarina; 2020 [citado 2023 Feb 15]. Disponível em: https://www.saude.sc.gov.br/coronavirus/arquivos/Manual%20de%20Orienta%C3%A7%C3%B5es%20da%20COVID-19%20v%C3%ADrus%20SARS-CoV-2%20de%20Santa%20Catarina%20-%2027%20de%20agosto.pdf
World Health Organization [Internet]. Coronavirus disease 2019 (COVID-19) Situation Report – 66. Geneva: WHO; 2023 [cited 2023 Nov 23]. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---23-november-2022
Ministério da Saúde [Internet]. Boletim epidemiológico especial: COVID-19. Semana Epidemiológica 46 de 13/10 a 19/10/2022. 2022 Out 19 [cited 2023 Apr 10]. Disponível em: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/boletins/epidemiologicos/covid-19/2022
Gerência de Vigilância das Doenças Imunopreveníveis e de Transmissão Hídrica e Alimentar (Distrito Federal, DF). Boletim epidemiológico Nº 876 [Internet]. Brasil: Secretaria de Estado de Saúde do Distrito Federal. 2022 Nov 29 [cited 2023 Jul 06]. Disponível em: https://www.saude.df.gov.br/documents/37101/0/Boletim_Covid_876.pdf
Pontes L, Danski MTR, Piubello SMN, Pereira JFG, Jantsch LB, Costa LB, Santos JO, Arrué AM, et al. Perfil clínico e fatores associados ao óbito de pacientes COVID-19 nos primeiros meses da pandemia. Esc Anna Nery. 2022;26:e20210203. Disponível em: https://www.scielo.br/j/ean/a/hd96H6fXGvWcbbZCdhSvV6J/?format=pdf&lang=pt. doi: https://doi.org/10.1590/2177-9465-EAN-2021-0203.
Ministério da Saúde [Internet]. COVID-19: Painel Coronavírus. Brasil: Ministério da Saúde; 2022. Disponível em: https://covid.saude.gov.br/
Secretaria de Estado de Saúde do Distrito Federal; Subsecretaria de Atenção Integral à Saúde; Câmara Técnica de Diretrizes e Orientações para o Manejo da COVID-19. Diretrizes sobre o diagnóstico e manejo clínico-farmacológico da COVID-19 em adultos. Brasília, DF: Governo do Distrito Federal; 2020. Disponível em : https://www.saude.df.gov.br/documents/37101/1264413/DIRETRIZES-SOBRE-O-DIAGNOSTICO-E-MANEJO-CLINICO-FARMACOLOGICO_DA_COVID_19_EM_ADULTO_3.1_Final.pdf
Wu Z, McGoonan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. Available from: https://pubmed.ncbi.nlm.nih.gov/32091533/. doi: https://doi.org/10.1001/jama.2020.2648
World Health Organization [Internet]. Number of COVID-19 cases reported to WHO [acesso em 29 nov 2022]. Available from: https://covid19.who.int/
Ministério da Saúde [Internet]. COVID-19 no Brasil [acesso em 29 nov 2022]. Disponível em: https://infoms.saude.gov.br/extensions/covid-19_html/covid-19_html.html
Faro A, Bahiano MA, Nakano TC, Reis C, Silva BFP, Vitti LS. COVID-19 e saúde mental: a emergência do cuidado. Estud psicol. 2020; 37:e200074. Disponível em: https://www.scielo.br/j/estpsi/a/dkxZ6QwHRPhZLsR3z8m7hvF/?format=pdf&lang=pt. doi: https://doi.org/10.1590/1982-0275202037e200074
Silva VR, Pacheco ES, Cardoso OO, Lima LHO, Rodrigues MTP, Mascarenhas MDM, et al. Tendência temporal das taxas de incidência e de mortalidade por COVID-19 e sua relação com indicadores socioeconômicos no Piauí: estudo ecológico, 2020-2021. Epidemiol Serv Saúde. 2022; 31(2):e20211150. Disponível em: https://www.scielo.br/j/ress/a/6zpZTM6xjkJ3YMbZgDXtDTH/#. doi: https://doi.org/10.1590/S2237-96222022000200022
Qun L, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. NEJM. 2020;382(13):1199-1207. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121484/. doi: https://doi.org/10.1056/NEJMoa2001316
Zhang J-J, Dong X, Cao Y-Y, Yuan Y-D, Yang Y-B, Yan Y-Q, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy Eur J Allergy Clin Immunol. 2020;75(7):1730–41 Available from: https://onlinelibrary.wiley.com/doi/10.1111/all.14238. Doi: https://doi.org/10.1111/all.14238.
Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health, 2020; 8: 152. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201103/. doi: https://doi.org/10.3389/fpubh.2020.00152
Salinas-Aguirre JE, Sánchez-Garcia C, Rodrígues-Sanchez R, Rodríguez-Muños L, Díaz-Castaño A, Bernal-Gómez E, et al. Características clínicas y comorbilidades asociadas a mortalidad en pacientes con COVID-19 en Coahuila (México). Rev Clín Esp. 2022; 222(5):288-292. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816557/. doi: https://doi.org/10.1016/j.rceng.2020.12.007
Kammar-Garcia, Vidal-Mayo JJ, Vera-Zertuche JM, Lazcano-Hernández M, Vera-López O, Segura-Badilla O, et al. Impacto f comorbities in Mexican SARAS-CoV-e positive patients: a retrospective analysis in a national cohort. Rev Invest Clín. 2020; 72 (3):151-158. Available from: https://www.clinicalandtranslationalinvestigation.com/frame_esp.php?id=284 doi: https://doi.org/10.24875/RIC.20000207
León-Jiménez F, Vives-Kufoy C, Failoc-Rojas VE, Valladares-Garrido MJ. Mortalidad en pacientes hospitalizados por COVID-19. Estudio prospectivo en el norte del Perú. Rev méd Chile. 2020;149(10): 1459-1466. Avaliable from: https://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021001001459&lng=en&nrm=iso&tlng=en doi: https://doi.org/10.4067/s0034-98872021001001459
Ibánez JMF, Ballesteros MCM, Andúgar MAG, Anguita MJF, Arias AA, Barberá-Farré JR, et al. Factores de riesgo de mortalidad en pacientes mayores de 65 años hospitalizados por COVID-19. Rev Esp Geriatr Gerontol. 2022;57(1):6-12. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585591/ doi: https://doi.org/10.1016/j.regg.2021.09.004
Huang BH, Inan-Eroglu E, Shaban RZ, Hamer M, Britton A, Stamatakis E, et al. Alcohol intake and mortality risk of COVID-19, pneumonia, and other infectious diseases: An analysis of 437191 UK biobank participants. Prev Med Rep. 2022; 28; 26:101751. Available from: https://pubmed.ncbi.nlm.nih.gov/35251915/. doi: https://doi.org/10.1016/j.pmedr.2022.101751
Sousa CDK, Morais TC, Daboin BEG, Portugal I, Cavalcanti MPE, Echeimberg JO, et al. Epidemiological profile of COVID-19 in the State of Espírito Santo, Brazil, from march 2020 to June 2021. J Hum Growth Dev. 2021; 31 (3): 507-520. Available from: http://pepsic.bvsalud.org/scielo.php?script=sci_arttext&pid=S0104-12822021000300017 doi: https://doi.org/10.36311/jhgd.v31.12770
Reis ECD, Rodrigues P, Jesus TR, de Freitas Monteiro EL, Junior JSV, Bianchi L, et al. Risk of hospitalization and mortality due to COVID-19 in people with obesity: An analysis of data from a Brazilian state. PLoS One. 2022; 4;17(3):e0263723. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896734/ doi: https://doi.org/10.1371/journal.pone.0263723
Foulkes AS, Selvaggi C, Shinnick D, Lumish H, Kim E, Cao T, et al. Understanding the Link Between Obesity and Severe COVID-19 Outcomes: Causal Mediation by Systemic Inflammatory Response. J Clin Endocrinol Metab. 2022; 18;107(2):e698-e707. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499919/ doi: https://doi.org/10.1210/clinem/dgab629
Sidhu G, Samson R, Nedunchezian SH, Srivastav S, Dixit N, Le Jemtel TH. COVID 19 in-hospital mortality, body mass index and obesity related conditions. J Diabetes Complications. 2021; 35(12):108054. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479419/#!po=96.6667. doi: https://doi.org/10.1016/j.jdiacomp.2021.108054
Custodio ACD, Ribas FV, Toledo LV, Carvalho CJ, Lima LM, Freitas BAC. Hospitalizations and mortality by severe acute respiratory syndrome: comparison between the pre-pandemic and pandemic periods. Ver Bras Epidemiol. 2021; 24:e210052. Available from: https://www.scielo.br/j/rbepid/a/KQ5swCNJ6WrDGjyvq8ypQbd/?format=pdf&lang=en doi: https://doi.org/10.1590/1980-549720210052
Hinks TSC, Cureton L, Knight R, Wang A, Cane JL, Barber VS, et al. Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial. Lancet Respir Med. 2021;9(10):1130-1140. Available from: https://pubmed.ncbi.nlm.nih.gov/34252378/. doi: https://doi.org/10.1016/S2213-2600(21)00263-0
Pei L, Zhang S, Huang L, Geng X, Ma L, Jiang W, et al. Antiviral agents, glucocorticoids, antibiotics, and intravenous immunoglobulin in 1142 patients with coronavirus disease 2019: a systematic review and meta-analysis. Pol Arch Intern Med. 2020; 130: 726-733. Available from: https://pubmed.ncbi.nlm.nih.gov/32749826/. doi: https://doi.org/10.20452/pamw.15543
Yasar Z, Yemisen M, Yasar H, Ertaş A, Meric K, Sahin S. Can treatment with teicoplanin improve the prognosis of COVID-19 patients? Int J Clin Pract. 2021;75(11):e14752. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646897/#:~:text=What's%20new-,Teicoplanin%20administration%20is%20associated%20significantly%20with%20lower,hospitalised%20patients%20with%20COVID%E2%80%9019. doi: https://doi.org/10.1111/ijcp.14752
Falavigna M, Stein C, Amaral JLG, Azevedo LCP, Belli KC, Colpani V, et al. Diretrizes Brasileiras para o tratamento farmacológico de pacientes hospitalizados com COVID-19: Diretriz conjunta da Associação Brasileira de Medicina Intensiva Brasileira, Associação Médica Brasileira, Sociedade Brasileira de Angiologia e Cirurgia Vascular, Sociedade Brasileira de Infectologia, Sociedade Brasileira de Pneumologia e Tisiologia e Sociedade Brasileira de Reumatologia. Rev Bras Ter Intensiva. 2022; 34(1):1-12. Disponível em: https://www.scielo.br/j/rbti/a/hbNqqXwv3L4csjb5HjmyqFv/#:~:text=no%20Material%20Suplementar.-,Corticosteroides,%2C%20certeza%20da%20evid%C3%AAncia%20moderada. doi: https://doi.org/10.5935/0103-507X.20220001-pt
Wang YC, Luo H, Liu S, Huang S, Zhou Z, Yu Q, et al. Dynamic evolution of COVID-19 on chest computed tomography: experience from Jiangsu Province of China. Eur Radiol. 2020;30(11):6194-6203. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283983/. doi: https://doi.org/10.1007/s00330-020-06976-6
Mena G, Montané E, Rodríguez M, Beroiz P, López-Núñez JJ, Ballester M. Caracterización y eventos adversos relacionados con la asistencia sanitaria en pacientes infectados por el SARS-CoV-2 fallecidos en un hospital de tercer nivel. Med Clin (Barc). 2021;26;156(6):277-280. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832921/. doi: https://doi.org/10.1016/j.medcli.2020.11.002
Backes MTS, Higashi GDC, Damiani PR, Mendes JS, Sampaio LS, Soares GL. Working conditions of Nursing professionals in coping with the Covid-19 pandemic. Rev Gaucha Enferm. 2021;42(spe):e20200339. Available from: https://www.scielo.br/j/rgenf/a/8m9tKBNXw8tWKyZjyPxmh4K/?lang=en#. doi: https://doi.org/10.1590/1983-1447.2021.20200339
Moreira RS. COVID-19: unidades de terapia intensiva, ventiladores mecânicos e perfis latentes de mortalidade associados à letalidade no Brasil. Cad Saude Publica. 2020; 36(5):e00080020. Available from: https://www.scielo.br/j/csp/a/NPz56K7Zys3fFDZdWHdcYWn/?format=pdf&lang=pt. doi: https://doi.org/10.1590/0102-311X00080020
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 José Victor Soares da Silva, Iara Caroline Moura Conceição da Silva, Elen Maysa de Almeida Silva, Nayara da Silva Lisboa, Luana Vieira Toledo
This work is licensed under a Creative Commons Attribution 4.0 International License.
Esta licença permite que outros distribuam, remixem, adaptem e desenvolvam seu trabalho, mesmo comercialmente, desde que atribuam crédito à revista pela criação original.
https://doaj.org/toc/2675-2913
